Results 31 to 40 of about 4,977 (176)

Infantile hemangioma: a brief review [PDF]

open access: yesMedicine and Pharmacy Reports, 2015
Infantile hemangiomas as frequent infancy tumors have been a controversial issue of medical scientists worldwide. Their clinical aspects are various and their physiopathology is yet to be fully understood. Numerous publications outline the characteristics, causes, evolution possibilities and therapeutic approaches.
BOTA, MADALINA   +3 more
openaire   +2 more sources

Progress in evidence-based research on the clinical treatment of infantile hemangioma and vascular malformations

open access: yes口腔疾病防治, 2021
Hemangiomas and vascular malformations are common clinical diseases. According to their clinical and imaging characterizations, the International Society for the Study of Vascular Anomalies (ISSVA) has systematically classified infantile hemangioma and ...
ZHENG Jiawei, ZHAO Zeliang
doaj   +1 more source

Infantile hemangioma: An update

open access: yesIndian Journal of Dermatology, Venereology, and Leprology, 2010
Infantile hemangiomas (IH) are neoplastic proliferations of endothelial cells, characterized by a period of growth after birth, and eventual spontaneous involution. The course can be uneventful, culminating in spontaneous resolution; or it may be marked by complications such as bleeding; ulceration; infection; visual, feeding and breathing compromise ...
Mendiratta, Vibhu, Jabeen, Masarat
openaire   +2 more sources

Propranolol for Infantile Hemangiomas [PDF]

open access: yesGlobal Advances in Health and Medicine, 2012
Hemangiomas are common vascular birthmarks that usually present a predictable pattern of proliferation and ultimate involution. Most do not require any treatment. When intervention is clinically indicated, medical and surgical options exist. Historically, corticosteroids have been used and have been shown to slow or stop the growth of a majority of ...
openaire   +2 more sources

Klippel‐Trénaunay‐Weber Syndrome: Prenatal Diagnosis and Review of the Literature

open access: yesJournal of Clinical Ultrasound, Volume 53, Issue 3, Page 535-546, March/April 2025.
This meta‐analysis demonstrates the high diagnostic accuracy of SZ‐CEUS for differentiating between malignant and benign focal liver lesions, as well as for HCC from non‐HCC lesions. The study shows better performance for smaller lesions and those with a higher proportion of malignancy.
Giuliana Orlandi   +13 more
wiley   +1 more source

Blinded by the Bot: Benchmarking GPT and Gemini Against Human Authors in Otolaryngology Reviews

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective To compare the quality of scientific review articles generated by two artificial intelligence systems, ChatGPT and Gemini, with those written by human authors in the field of otolaryngology. Methods Two otolaryngology topics, chronic rhinosinusitis and infantile subglottic hemangioma, were selected.
Sholem Hack   +8 more
wiley   +1 more source

Clinical characteristics of infantile haemangioma in twins: a retrospective study

open access: yesBMC Pediatrics
Background Infantile hemangioma is one of the most common benign soft tissue tumors in infants. The pathogenesis of infantile hemangioma remains unclear and twin studies regarding its incidence may help clarify disease pathogenesis.
Zhengwei Sun   +3 more
doaj   +1 more source

Three-Dimensional Microtumor Formation of Infantile Hemangioma-Derived Endothelial Cells for Mechanistic Exploration and Drug Screening

open access: yesPharmaceuticals, 2022
Infantile hemangioma (IH) is the most prevalent type of vascular tumor in infants. The pathophysiology of IH is unknown. The tissue structure and physiology of two-dimensional cell cultures differ greatly from those in vivo, and spontaneous regression ...
Yanan Li   +5 more
doaj   +1 more source

Early Intervention Effects and Risk Factors for Residual Skin Changes in Infantile Hemangiomas

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Infantile hemangioma (IH) characteristically progresses through proliferative, involuting, and involuted phases, and typically undergoes spontaneous regression after the age of five. Therefore, the traditional management strategy has been based on a “wait‐and‐see policy”.
Kayoko Okuda   +4 more
wiley   +1 more source

NOGOB receptor–mediated RAS signaling pathway is a target for suppressing proliferating hemangioma

open access: yesJCI Insight, 2021
Infantile hemangioma is a vascular tumor characterized by the rapid growth of disorganized blood vessels followed by slow spontaneous involution. The underlying molecular mechanisms that regulate hemangioma proliferation and involution still are not well
Wenquan Hu   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy